Purpose: Our purpose was to compare the embryo culture performance of two types of petri dishes (Nunc and Falcon
INTRODUCTION
The successful culture of human embryos in an in vitro fertilization (IVF) program, resulting in high preg-nancy rates after embryo transfer (ET), is the major concern of the laboratory. This is one of the reasons that continuous efforts are made to improve culture media for embryo development. Human preimplantation embryo development up to the blastocyst stage has been achieved in at least seven media-modified Earle's balanced salt solution, minimum essential medium, human tubal fluid, Ham's, F10, and F12 (1-5)-and the list is still growing. Underlying all these efforts to improve culture media is the assumption that the basic physicochemical environment in which human embryos are cultured is inherently nontoxic. A possible source of trouble frequently neglected is the plastic material with which embryos make contact (6) . Studies concerning the culture performance of dishes are scarce but have shown that these plastics may be contaminated with plasticizing and molding agents (7) and that comparison of two very popular types of petri dishes may reveal adverse effects on the embryo culture (6) . Concerned by the global quality of our work, we explored the embryo culture performance of the Nunc petri dish (35 X 10 mm, Ref. 
MATERIALS AND METHODS

Petri Dishes
To avoid fluctuations in the material and equipment used in our embryo culture system, a general rule in our laboratory is to keep batches constant over the largest possible period. During this study we used batch L8019P for the Falcon dishes produced in the United Kingdom and batch 032946 for the Nunc dishes. No special treatment was applied to the dishes, either by washing or airing. The dishes used for mouse and human culture were always taken from unopened bags. They were prepared the day before gamete collection to allow full equilibration of the medium in a 5% O 2 CO 2 incubator.
Preclinical Animal Experimentation
As part of the routine quality control procedure, new items for our laboratory are exposed to the mouse zygote bioassay; both types of dishes were tested prior to the clinical trials (8) . For this purpose we used 6-to 8-week-old F 1 females obtained from C57 black females and CBa/ca males. The F 1 females were submitted to a 13-hr-light and 11-hr-dark regime. The light period started at 10 AM and ended at 11 PM. Disturbing this regime was avoided by keeping the cages with the mice in ventilated coffins. Superovulation was obtained by intraperitoneal injection of 10 IU of Folligon (Intervet Belgium) at 5 PM on day 1 and 10 IU of Chorulon (Intervet, Belgium) on day 3 at 4 PM. The injected F| females were then immediately mated with F 1 males. The females that had a clear vaginal plug at 10:30 AM on day 4 were sacrificed by cervical dislocation. The ampoules with the zygotes were dissected from the oviducts and placed in modified 20 mM Hepes-buffered Earle's balanced salt solution (EBSS) supplemented with 0.5% bovine serum albumin (BSA) fraction V and transported at 37°C from the animal house to the IVF laboratory. The modification of the EBSS consisted in adding 0.43 mM sodium pyruvate and 44 mM sodium lactate. The ampoules were disrupted with two forceps and the cumulus was removed by exposure to 20 mM Hepesbuffered EBSS, 0.5% BSA containing 80 IU/ml hyaluronidase. Zygotes were washed in three steps with 20 mM Hepes buffered EBSS, 0.5% BSA before they were equally distributed in the two types of petri dishes. These dishes contained the same modified EBSS with 0.5% BSA but buffered this time with 23.8 mM sodium bicarbonate. The dishes were prepared the day before by covering with mineral oil in each dish 3 drops of 300 Ul EBSS. The mouse zygote culture was performed under 5% CO 2 , 5% O 2 , 90% N 2 atmosphere at 37°C. The number of two-cell stage embryos at 24 hr of culture and the number of expanded blastocysts at 120 hr of culture were registered for both types of dishes.
Clinical Trials
Ovarian Stimulation and Oocyte Retrieval. Details of the ovarian stimulation protocol using gonadotropin releasing hormone analogue (GnRH-a) (buserelin acetate, Suprefact spray; Hoechst Inc., Frankfurt, Germany), human menopausal gonadotropin [hMG; Humegon (Organon Inc., Oss, The Netherlands) and Pergonal, (Serono Inc., Aubonne, Switzerland)], and human chorionic gonadotropin [hCG; Pregnyl Organon Inc.] and Profasi (Serono Inc.)], oocyte retrieval through vaginal puncture under ultrasound guidance, embryonic culture in modified EBSS, and transcervical replacement have been described elsewhere (9) . The age of the patients in the first clinical trial ranged between 26 and 43 years, with a median of 34 years. In the second trial the age ranged between 21 and 42 years, with a median of 32 years, and was not different.
Semen Preparation. Semen samples were prepared by the migration sedimentation gravity (MSG) technique (10) . Seminal plasma was washed out in centrifugation steps of 10 min at 500g. During the first step, 2 vol of Hepes-buffered modified EBSS was added and the supernatant was removed, and during the second step, the resuspended pellet was washed with 10 ml of bicarbonate-buffered EBSS. After removing the supernatant, the pellet was resuspended in 200 Ul of bicarbonate-buffered EBSS and the whole suspension was placed in the special MSG tube. After an incubation of 30 min at 37°C the tube was kept for 2 to 3 hr at room temperature. At the end of this incubation period a 200-Ul aliquot was taken from the bottom on the internal conical part of the MSG tube.
Human Embryo Culture and Embryo Replacement. The clinical trials were approved by the local committee forbioethics of the hospital. Two trials were conducted consecutively on the the couples referred to our fertility clinic for a classical IVF treatment without intracytoplasmic sperm injection. The first trial consisted in culturing, for each patient, half of the oocytes in one type of dish and the remaining half in the other type of dish. We decided to culture, for each patient, the odd oocytes in Nunc petri dishes and the even oocytes in Falcon petri dishes. Both types of dishes were prepared with the same batch of EBBS supplemented with 0.5% human serum albumin (HSA; Belgium Red Cross) the day before oocyte retrieval. Each type of dish contained 5 drops of 30 Ul of EBSS, 0.5% HSA covered with mineral oil. The oocytes of each patient were inseminated with the same number of spermatozoa obtained from the same semen preparation of the corresponding partner, in both types of dishes at the same time. The first trial was composed of 50 IVF cycles from 49 patients. We then conducted a second trial for another 50 classical IVF treatment cycles. A permutated randomized list was used to decide wether all oocytes of the patient had to be cultured in the Nunc or the Falcon dishes. This second clinical trial allowed us to compare the implantation rates.
Assessment of Fertilization, Embryo Cleavage, and Pregnancy. The presence of two pronuclei was controlled exactly 18 hr after insemination. Oocytes were considered fertilized only if they exhibited two clear pronuclei. Precisely 42 hr after insemination the cleavage stage was recorded and a score was given to the embryos. The scoring scale is based on the presence of anucleated cytoplasmic fragments, regularity, and number of blastomeres, with a maximum of 6 points per embryo (11) . A maximum of three embryos was replaced. Pregnancies were diagnosed by at least two positive hCG measurements (>1 mIU/ml; Behring Inc., Germany) 3 days apart, the first not being before day 11 after oocyte retrieval.
Statistical Analysis
Statistical analysis was performed with the SPSS statistical package using contingency table analysis to compare the distribution of fertilization, cleavage, and embryo quality. Table I resumes the results of four mouse zygote tests. No differences were observed in the number of two-cell-stage embryos and the number of expanded blastocysts after 120 hr of culture in both types of dishes.
RESULTS
Preclinical Animal Experimentation
Clinical Trials
Trial 1: Fertilization-Cleavage-Embryo Quality. A total of 517 human oocyte-cumulus complexes (OCC) was distributed between the two types of dishes for each patient. The number of oocytes found per patient ranged between 1 and 23, with a median of 9 oocytes per patient. Two hundred forty-eight OCC were cultured in the Falcon dishes and 269 OCC in the Nunc dishes. Of these 50 cycles, 23 clinical pregnancies were obtained. Table II illustrates the fertilization in both types of dishes; no differences were observed.
Table III describes the cleavage stage for both types of dishes after 45 hr of culture; no differences were observed.
The embryo quality as reflected by the score given to each embryo is reported in Table IV ; no differences were observed. To guarantee the best chances for the patients, we used the embryos with the highest score for embryo transfer, as usual. This generated a situation where, for the same patient, embryos cultured in both types of dishes were combined in the same transfer. This prevented us from drawing conclusions concerning possible differences in implantation rate between the two types of dishes. This was the reason for the conduction of the second clinical trial.
Trial 2: Implantation Rate. This trial was composed by 50 classical IVF treatment cycles from 44 patients. The number of oocytes recovered per patient Table V .
DISCUSSION
While the debate on the use of animal models as quality control systems for human IVF laboratories is still going on, we published our own findings with mouse models and showed the benefit of using minimal performance criteria to keep the fertilization and embryo quality high in classical IVF (8). In the abovedescribed randomized autocontrolled study, we were unable to detect differences in embryo culture performance between Nunc and Falcon petri dishes and now feel as comfortable using the Nunc dishes. We still have to consider that the "purity" of plastic used for culture dishes must not be taken for granted and that the effect of possible embryotoxic substances is masked in the worst situation and continues to exert a covered effect, discovered only after embryo replacement, or is totally neutralized in the best situation by the presence of sufficient amounts of amino acids, BSA, serum, or human albumin in the culture medium (6) . All these arguments give good reasons not to neglect the quality of basic disposable materials used in human embryo culture and to admit that batch-to-batch variations may occur.
We have pointed out in previous work that the mouse bioassay has limited sensitivity, and it is without a doubt the most labor-intensive part of our quality control setup (8) , especially if all new items and every new batch are tested before their use in the human IVF program. However, presuming that all items available for human embryo culture are "gold standards" is naive and may, sooner or later, result in unsatisfactory "baby home-take" rates.
